UCB and Amgen’s osteoporosis drug shows promise
April 21, 2011Research and Development Amgen, UCB, osteoporosis
Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …
Report sounds off-label prescribing warning
April 21, 2011Sales and Marketing EAASM, off label
A pharma-backed group has warned that some ‘off-label’ prescribing is dangerous for patients. A report by the European Alliance for …
Trevor Smith to lead Takeda in Europe
April 21, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …
Saving billions through ‘innovation’ – can the NHS pull it off?
April 21, 2011NHS reforms
Innovation is not a concept immediately associated with the UK’s national health service, but is now being promoted by the …
Procurement pitfalls and hurdles of lab equipment for clinical trials
April 20, 2011Research and Development clinical trials, medical equipment, mesm, procurement
Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …
Eisai launches cancer drug Halaven in UK
April 20, 2011Sales and Marketing Eisai, Halaven, breast cancer
Eisai’s sea sponge derived breast cancer drug Halaven has been launched in the UK following approval from European regulators a …
Novavax appoints Stanley Erck chief executive
April 20, 2011Research and Development appointment, research and development
US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …
Generics push US drug growth to $307bn
April 20, 2011IMS, IMS Health, drug spending, healthcare spending
Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …
Warner Chilcott plans to axe 500 jobs in Europe
April 20, 2011Manufacturing and Production, Research and Development, Sales and Marketing Warner Chilcott, pharma job cuts
Warner Chilcott is looking to cut 500 jobs from its European operations as it seeks to minimise the impact of …
Contract research news in brief
April 20, 2011Research and Development CRO, contract research
Our contract research news round-up features updates from BioClinica, Vyteris, CROMSOURCE, Quintiles, Imperial/D. Anderson and PRA International. Clinical trial management …
Life Healthcare Communications expands
April 20, 2011Medical Communications appointment, medical communications
Life Healthcare Communications has expanded, adding new employees and extending its existing digital department.The Berkshire, UK-based creative communications agency has …
Circassia raises funds to develop allergy products
April 19, 2011Research and Development Circassia, UK biotech, biotech
UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
Oral MS drug Gilenya launched in the UK
April 19, 2011Sales and Marketing Novartis, gilenya, multiple sclerosis
Gilenya has become the first oral multiple sclerosis drug to be launched in the UK. Gilenya (fingolimod) is licenced to …
NICE unimpressed with Novartis’ patient access scheme
April 19, 2011Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis
Novartis has been dealt a blow by NICE after the cost-effectiveness body finally refused to recommend, on appeal, its kidney …
FDA issues guidance on preventing antibiotic cross-contamination
April 19, 2011Manufacturing and Production FDA, GMP, pharma manufacturing
The FDA has published a new guidance document to help drugmakers prevent cross-contamination of pharmaceuticals with non-penicillin beta-lactam antibiotics. The …
Organogenesis to build ‘largest automated living cell facility’
April 19, 2011Manufacturing and Production Cell biology, Organogenesis, pharma manufacturing
Regenerative medicine specialist Organogenesis has started construction of an automated manufacturing facility for human cells, which it claims will be …
J&J and Merck reach compromise on arthritis drug rights
April 19, 2011Sales and Marketing Johnson & Johnson, Merck & Co, Remicade, Simponi
Johnson & Johnson and Merck & Co have agreed to split the regional rights to arthritis drugs Remicade and Simponi …
GlaxoSmithKline OTC sale puts two plants on the block
April 19, 2011Manufacturing and Production GSK, US, pharma manufacturing
GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …
Boehringer’s Pradaxa recommended for expanded European licence
April 18, 2011Sales and Marketing Boehringer Ingelheim, CHMP, Pradaxa
Pradaxa is on course to expand its European licence with a recommendation from the CHMP for a new indication in …
Tim Mustill and Jenny Hepburn join InterPhase
April 18, 2011Sales and Marketing appointment, sales and marketing
KnowledgePoint360 Group has appointed Tim Mustill and Jennifer Hepburn to key positions within its strategic consulting practice InterPhase. Tim has …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
